Biostar Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Net Income before Extraordinaries
19,997.30
809.00
4,848.20
25,112.60
5,698.40
Depreciation, Depletion & Amortization
1,827.90
2,786.70
3,086.20
2,320.20
1,142.50
Other Funds
1,584.40
1,614.40
-
-
-
Funds from Operations
9,885.40
6,673.40
9,386.50
528.90
2,395.40
Changes in Working Capital
6,301.70
2,235.70
6,075.90
5,348.30
7,308.10
Net Operating Cash Flow
3,583.70
8,909.10
3,310.60
5,877.20
4,912.70
Capital Expenditures
32.90
982.00
2,869.20
59.50
6,378.10
Sale of Fixed Assets & Businesses
21.80
-
2.90
-
-
Purchase/Sale of Investments
-
-
-
8,122.20
-
Net Investing Cash Flow
17,288.80
4,210.80
8,878.10
7,377.50
6,378.10
Issuance/Reduction of Debt, Net
3,961.00
4,843.20
3,091.60
160.80
278.30
Net Financing Cash Flow
5,545.30
6,457.50
6,954.10
160.80
1,411.20
Net Change in Cash
15,212.70
1,679.00
1,605.10
1,646.30
134.40
Free Cash Flow
3,616.60
7,927.10
441.40
5,817.70
1,465.50
Deferred Taxes & Investment Tax Credit
2,036.10
981.40
4,284.70
1,333.00
2,653.10
Net Assets from Acquisitions
823.90
-
-
-
-
Other Sources
1,766.60
3,390.20
2,937.50
804.20
-
Change in Capital Stock
-
-
3,862.50
-
1,689.50
Exchange Rate Effect
114.40
80.20
218.50
14.90
188.70
Other Uses
18,220.40
6,619.00
8,949.30
-
-
About Biostar Pharmaceuticals
View Profile
